This next-generation peptide could be a game-changer for weight management, and were here to share what makes it so exciting
Product Description Compound Specifications Full Name: Retatrutide Analog (GLP3-R) Sequence Type: Multi-receptor incretin-associated peptide analog Target Pathways: GLP-1, GIP, and glucagon receptor signaling Molecular Weight: ~4731 g/mol Structure Notes: Structurally modified peptide analog incorporating targeted amino acid substitutions and lipidation to support prolonged receptor interaction and signaling stability Overview GLP3-R is a multi-receptor peptide analog frequently incorporated into experimental models examining how coordinated GLP-1 , GIP , and glucagon receptor signaling influences nutrient-responsive metabolic systems
Karla works with eligible patients exploring wellness-focused peptide programs, including Tesamorelin, Ipamorelin, CJC-1295, GHK-Cu, GLOW Mix, KLOW, Wolverine Blend, NAD+ therapy, and physician-guided medical weight loss programs
Certain clinical scenarios might warrant a more gradual approach to discontinuation, even though not pharmacologically necessary
Most side effects are transient and resolve within the first weeks of treatment
Bishop, A
